The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion